Ozempic vs Tirzepatide: Complete Comparison
Wondering how Ozempic and Tirzepatide compare? This guide breaks down the key differences in ingredients, dosing, FDA approvals, and who each medication may be best suited for. Use the comparison below to have an informed conversation with your healthcare provider.
Side-by-Side Comparison
| Feature | Ozempic | Tirzepatide |
|---|---|---|
| Generic Name | semaglutide | tirzepatide |
| Molecule Type | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| Manufacturer | Novo Nordisk | Compounding pharmacies |
| FDA Approval | Type 2 diabetes | Compounded products are not FDA-approved |
| Available Doses | 0.25mg, 0.5mg, 1mg, 2mg | Custom (compounded doses vary) |
| Half-Life | ~7 days | ~5 days (published data for FDA-approved tirzepatide) |
| Dosing Frequency | Once weekly | Once weekly |
Key Differences
- •Ozempic is a brand-name GLP-1 agonist (semaglutide by Novo Nordisk), while tirzepatide is a different molecule, a dual GIP/GLP-1 agonist, which is also prescribed as compounded preparations that are not FDA-approved.
- •These are fundamentally different molecules: semaglutide activates only GLP-1 receptors, while tirzepatide activates both GIP and GLP-1 receptors.
- •Ozempic has full FDA approval with extensive clinical trial data, while compounded tirzepatide lacks FDA approval as a product.
- •Compounded tirzepatide may be significantly cheaper than brand-name Ozempic, but with less quality assurance.
- •The half-lives differ: Ozempic ~7 days vs tirzepatide ~5 days, which affects medication level stability throughout the week.
Who Should Consider Each Medication?
Who May Prefer Ozempic
Patients who want FDA-approved medication with guaranteed quality and extensive safety data, those with insurance coverage for Ozempic, or patients satisfied with GLP-1-only therapy.
Who May Prefer Tirzepatide
Patients whose doctors recommend tirzepatide based on their clinical profile. Clinical trial results for tirzepatide come from the FDA-approved products (Mounjaro, Zepbound) and do not apply to compounded tirzepatide, which has not been studied in those trials.
Track Either Medication with JellyPal
Whether you choose Ozempic or Tirzepatide, JellyPal helps you track injections, visualize medication levels, monitor side effects, and share reports with your doctor. Our pharmacokinetic plotter shows an estimate based on published pharmacokinetic data for each medication; it may not reflect the pharmacokinetics of a specific compounded formulation.
This comparison is for informational purposes only and is not medical advice. Both Ozempic and Tirzepatide are prescription medications that should only be taken under the supervision of a qualified healthcare provider. Consult your doctor to determine which medication is appropriate for your individual needs.

